A Search Service for Abbreviation / Long Form

■ 関連PubMed/MEDLINE情報

合計出現文献数: 83
/ ページ
略語 : RT
展開形 : radiotherapy alone
No. 発表年 題目 共起略語
2022 Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial. CCRT, ESCC, ORR, OS, PFS
2021 A cost-effectiveness analysis of front-line treatment strategies in early-stage follicular lymphoma. CMT, ICERs, QALYs, WTP
2021 Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience. CMT, CT, ENKTL, OS, PFS
2021 Effectiveness comparisons of various therapies for FIGO stage IB2/IIA2 cervical cancer: a Bayesian network meta-analysis. CCRT, RS
2021 Opioid therapy vs. multimodal analgesia in head and neck Cancer (OPTIMAL-HN): study protocol for a randomized clinical trial. 11-NRS, CRT, HNC, OPTIMAL-HN, RIM
2021 PD-1 Blockade With Concurrent Radiotherapy for Locally Advanced Inoperable Cutaneous Squamous Cell Carcinoma. Cem-RT, LA-cSCC
2021 Radiotherapy Plus Chemotherapy Is Associated With Improved Survival Compared to Radiotherapy Alone in Patients With Primary Vaginal Carcinoma: A Retrospective SEER Study. IPW, RT-CT
2021 Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study. ATC, CSS, IPW, IQR, OS, RCT
2020 Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy. CTRT, EC, MMR, MMRd, p53abn, POLEmut, RFS
10  2020 Significant impact on the oncologic outcomes with intensity modulated radiotherapy and conformational radiotherapy over conventional radiotherapy in cervix cancer patients treated with radiotherapy. CRT, CSS, EFS, IMRT, OS
11  2019 Long-Term Survival Rates and Prognostic Factors of Cervix Cancer Treated by Different Modalities. CRT, OS
12  2019 The addition of chemotherapy to radiotherapy did not reduce the rate of distant metastases in low-risk HPV-related oropharyngeal cancer in a real-world setting. CRT, DM, HPV
13  2018 Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial. DFS, FIGO, OS, RT arm
14  2018 Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis. CCRT, IMRT, LA-NPC, RR
15  2018 Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry. OBS, OS, RCT, RFS
16  2018 Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)-Lung Working Group. AIRO, CT, CT-RT, HypoRT, NSCLC, OS
17  2018 Preoperative radiotherapy or chemoradiotherapy in rectal cancer - Is survival improved? An update of the "Nordic" LARC study in non-resectable cancers. CRT
18  2018 Radiotherapy combined with zoledronate can reduce skeletal-related events in renal cell carcinoma patients with bone metastasis. PI, RCC, SRE
19  2017 A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients. CI, CRT, HR, LP, OS
20  2017 Chemoradiation combined with regional hyperthermia for advanced oesophageal cancer: a systematic review and meta-analysis. CRT, HCRT, RCTs
21  2017 The population benefit of evidence-based radiotherapy: 5-Year local control and overall survival benefits. CRT, LC, OS
22  2016 Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer. EMT, HF, LLC, NC
23  2016 Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma. CT, HNSCC
24  2016 The population benefit of radiotherapy for gynaecological cancer: Local control and survival estimates. CRT, GC, LC, OS
25  2016 Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma. CCRT, ENKTL, LRC, OS, PFS, SCRT
26  2014 A comparison of outcomes for early oropharyngeal cancers treated with single-modality surgery versus radiotherapy. ---
27  2014 Healthcare costs associated with skeletal-related events in breast cancer patients with bone metastases. PF, SB, SCC, SD, SREs
28  2014 Investigation of uterine arterial chemoembolization and uterine arterial infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study. DSS, MFS, PC, UACE, UACE, UAIC
29  2013 Combined radiochemotherapy in patients with locally advanced pancreatic cancer: a meta-analysis. CRT, CT, LAPC
30  2013 Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy? CR, CT, FL, OS, PFS, Ri, RT-CT, WW
31  2013 The significance of combining radiotherapy with chemotherapy for early stage extranodal natural killer/T-cell lymphoma, nasal type: a systematic review and meta-analysis. CI, CMT, CR, NK, OR, OS, PFS
32  2012 Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression? MSCC
33  2012 IMRT for locally advanced anal cancer: clinical experience of the Montpellier Cancer Center. CAC, GI, GU, IMRT
34  2012 Radiotherapy in elderly patients with inoperable esophageal cancer. Is there a benefit? OS, PFS, RCT
35  2012 [Nutritional surveillance in head and neck cancer patients during radiotherapy--the difference between concurrent chemoradiotherapy using high-dose cisplatin and radiotherapy alone]. CCRT, PEG
36  2011 Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx. CRT, LEDFS
37  2011 Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. DDSS, LE, MSCC
38  2010 Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. CENTRAL, CI, HR, LACC, OS, RCTs, RHT, RR
39  2010 Combined use of hyperthermia and radiation therapy for treating locally advanced cervix carcinoma. CENTRAL, CI, HR, LACC, OS, RCTs, RHT, RR
40  2010 Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. CRT, FFR
41  2009 Local control and survival following concomitant chemoradiotherapy in inoperable stage I non-small-cell lung cancer. CRT, FDG-PET, NSCLC, PFS
42  2009 Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort. CI, CRT, HR, SEER
43  2009 Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma. CSS, CT, OBS, PFS, UPSC
44  2009 Postoperative concurrent nedaplatin-based chemoradiotherapy improves survival in early-stage cervical cancer patients with adverse risk factors. CCRT, OS, PFS
45  2009 Predictors of outcome for advanced-stage supraglottic laryngeal cancer. DSS, OS, SRT
46  2008 Amifostine use in radiation-induced kidney damage. Preclinical evaluation with scintigraphic and histopathologic parameters. CL
47  2008 Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. CRT, NPC
48  2008 [Retrospective study of chemoradiotherapy based on cisplatin compared with radiotherapy alone for cervical cancer]. CRT
49  2007 Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine. aGD, RCT
50  2006 A prospective comparison of multidisciplinary treatment of oesophageal cancer with curative intent in a UK cancer network. CRT, MDT
51  2006 Anal carcinoma of the elderly treated with radiotherapy alone or with concomitant radio-chemotherapy. LRC, OS, pts
52  2006 Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications. CMT, HD, LDIFRT, STNI
53  2006 Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. CI, CRT, CT, EF, HL, IF, OR, SMR
54  2005 Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials. CRT, NPC
55  2005 Standard thoracic radiotherapy with or without concurrent daily low-dose carboplatin in elderly patients with locally advanced non-small cell lung cancer: a phase III trial of the Japan Clinical Oncology Group (JCOG9812). CI, CRT, NSCLC, TRDs
56  2004 A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung. NSCLC, WBRT
57  2004 Effect of adjuvant androgen deprivation on thyroid function tests in prostate cancer patients. AD, TSH
58  2004 The rational principles of neo-adjuvant therapy for rectal cancer. TME
59  2003 A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix. BOMP
60  2003 Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients. a prospective, comparative, non-randomised study. CTC
61  2003 Cardiovascular disease as a long-term complication of treatment for testicular cancer. CI, RR
62  2003 Early morbidity after radiotherapy with or without chemotherapy in advanced head and neck cancer. Experience from four nonrandomized studies. ---
63  2002 Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma. CR, NPC
64  2002 Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. CMT, CR, DFS, ECOG, NK, OS
65  2001 A treatment trade-off based decision aid for patients with locally advanced non-small cell lung cancer. CMT
66  2001 Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer. CMT, LA-NSCLC, SAT
67  2000 A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy. CHOP, Gy, HR, PCL
68  2000 Sequential re-analysis of a phase-III clinical trial in non-small cell lung cancer. CTRT
69  2000 Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: A comparative review of 22 articles. ---
70  1998 Effectiveness of RF capacitive hyperthermia combined with radiotherapy for stages III and IV oro-hypopharyngeal cancers: a non-randomized comparison between thermoradiotherapy and radiotherapy. RF, TRT
71  1998 [Treatment of Hodgkin's disease with bulky mediastinal involvement. Study of 28 cases]. CT, HD
72  1997 Is combined modality therapy necessary for advanced Hodgkin's disease? CMT
73  1997 Radiotherapy for pituitary adenoma: long-term outcome and sequelae. ---
74  1995 Conservative versus nonconservative treatment of epidermoid carcinoma of the anal canal for tumors longer than or equal to 5 centimeters. A retrospective comparison. RS
75  1993 [Urodynamic evaluation for bladder dysfunction after radical hysterectomy]. MRH, RH
76  1992 Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034. CT/RT
77  1992 First analysis of tumor regression for the European randomized trial of etanidazole combined with radiotherapy in head and neck carcinomas. ETA
78  1992 Locally advanced breast cancer: report of phase II study and subsequent phase III trial. ---
79  1991 The place of radiotherapy in stage I and IIA Hodgkin's disease (or radiotherapy revisited). CT
80  1990 [Treatment results of maxillary sinus carcinoma. A retrospective study]. ---
81  1989 Late regrowth of pituitary adenomas after irradiation and/or surgery. Hazard function analysis. ---
82  1989 Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: a Report by the Radiation Therapy Oncology Group. CR
83  1983 A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. ---